1. Directory
  2. New Hampshire
  3. Advancing Cancer Treatment
EIN 83-2886283

Advancing Cancer Treatment

IRS 501(c) type
501(c)(3)
Num. employees
0
City
Moultonborough
State
New Hampshire
Year formed
2018
Most recent tax filings
2022-12-01
NTEE code, primary
G30: Cancer
Description
Advancing Cancer Treatment aims to make the Washington, DC Metropolitan Area a leader in advancing clinical trial accrual to accelerate improved cancer care and treatment. Currently, ACT focuses on improving prostate cancer trial accrual through creating a registry that aims to get a significant portion of patients to participate by submitting a simple saliva test.
Total revenues
$3,010,183
2022
Total expenses
$3,103,502
2022
Total assets
$683,975
2022
Num. employees
0
2022

Program areas at Advancing Cancer Treatment

Act's current focus is improving accrual to prostate Cancer clinical trials. Act's goal is to create a prostate registry aimed at getting a significant portion of prostate Cancer patients to sign up to participate by submitting a simple saliva test that will provide their genetic information for research, and provide an alert service to them if any treatments or therapies match their profile and could help change their outcome.

Who funds Advancing Cancer Treatment

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$2,500,000

Personnel at Advancing Cancer Treatment

NameTitleCompensation
Pamela BrownVice President , Secretary$0
David BrownPresident , Treasurer$0

Financials for Advancing Cancer Treatment

RevenuesFYE 12/2022
Total grants, contributions, etc.$3,000,000
Program services$0
Investment income and dividends$10,183
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$3,010,183

Form 990s for Advancing Cancer Treatment

Fiscal year endingDate received by IRSFormPDF link
2022-122023-08-21990View PDF
2021-122022-11-17990View PDF
2021-122022-06-23990View PDF
2020-122021-05-20990View PDF
2019-122021-01-21990View PDF
Data update history
October 4, 2023
Posted financials
Added Form 990 for fiscal year 2022
June 13, 2023
Posted financials
Added Form 990 for fiscal year 2021
May 9, 2023
Used new vendors
Identified 1 new vendor, including
May 21, 2022
Used new vendors
Identified 2 new vendors, including , and
May 20, 2022
Posted financials
Added Form 990 for fiscal year 2020
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Provides grantsConducts researchTax deductible donationsNo full-time employees
General information
Address
42 Ruppert Rd
Moultonborough, NH 03254
County
Carroll County, NH
Website URL
actclinicaltrials.org/ 
Phone
(972) 935-6510
IRS details
EIN
83-2886283
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2018
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
G30: Cancer
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when Advancing Cancer Treatment has new information, or want to find more organizations like Advancing Cancer Treatment?

Create free Cause IQ account
Cause IQ is a website that helps companies grow, maintain, and serve their nonprofit clients, and helps nonprofits find additional foundation funding. Our data and tools help professionals prospect for nonprofits, research opportunities, benchmark their clients, and enrich existing information.
Nonprofits
Product
Customers
About

© 2024 Nonprofit Metrics LLC
Terms of Service and Privacy Policy